Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo

Neuroscience Letters

Volumn 304, Issue 3, 2001, Pages 185-188

  Lee, Song Chu ^a   Schwarcz, Robert ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Astrocytes; Excitotoxicity; Glia; Kynurenines; N methyl D aspartate; Neurodegeneration; Neuroprotection

Indexed keywords

7 CHLOROKYNURENIC ACID; KYNURENINE; LEVO 4 CHLOROKYNURENINE; N METHYL DEXTRO ASPARTIC ACID; PRODRUG; QUINOLINIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG METABOLISM; DRUG UPTAKE; GLIA CELL; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; INJECTIONS, INTRAPERITONEAL; KYNURENIC ACID; KYNURENINE; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OSMOLAR CONCENTRATION; PRODRUGS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035947210     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01791-8     Document Type: Article

References (20)

1. Ceresoli-Borroni G., Guidetti P., Schwarcz R. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. J. Neural Transm. 106:1999;229-242.
2. Danysz W., Parsons C.G. Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol. Rev. 50:1998;597-664.
3. Gramsbergen J.B.P., Hodgkins P.S., Rassoulpour A., Turski W.A., Guidetti P., Schwarcz R. Brain-specific modulation of kynurenic acid synthesis in the rat. J. Neurochem. 69:1997;290-298.
4. Greene J.G., Greenamyre J.T. Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48:1996;613-634.
5. Guidetti P., Wu H.-Q., Schwarcz R. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum. Exp. Neurol. 163:2000;123-130.
6. Hodgkins P.S., Schwarcz R. Uptake and metabolism of 4-chlorokynurenine in rat brain slices: studies on the regulation of 7-chlorokynurenic acid synthesis. Soc. Neurosci. Abstr. 24:1998;463.
7. Hodgkins P., Wu H.-Q., Zielke H.R., Schwarcz R. 2-Oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo. J. Neurochem. 72:1999;643-651.
8. Hokari M., Wu H.-Q., Schwarcz R., Smith Q.R. Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid. NeuroReport. 8:1996;15-18.
9. Landis D.M. The early reactions of non-neuronal cells to brain injury. Ann. Rev. Neurosci. 17:1994;133-151.
10. Leeson P.D., Iversen L.L. The glycine site on the NMDA receptor - activity relationships and therapeutic potential. J. Med. Chem. 37:1994;4053-4067.
11. Moroni F., Russi P., Lombardi G., Beni M., Carlà V. Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51:1988;177-180.
12. Salituro F.G., Tomlinson R.C., Baron B.M., Palfreyman M.G., McDonald I.A., Schmidt W., Wu H.-Q., Guidetti P., Schwarcz R. Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor. J. Med. Chem. 37:1994;334-336.
13. Schwarcz R., Du F., Schmidt W., Turski W.A., Gramsbergen J.B.P., Okuno E., Roberts R.C. Kynurenic acid: a potential pathogen in brain disorders. Langston J.W., Young A. Neurotoxins and Neurodegenerative Disease. Ann. N.Y. Acad. Sci. 1992;140-153 New York.
14. Schwarcz R., Whetsell W.O. Jr., Mangano R.M. Quinolinic acid: An endogenous metabolite that causes axon-sparing lesions in rat brain. Science. 219:1983;316-318.
15. +-independent transporter of neutral amino acids in astrocytes. J. Neurosci. 9:1989;2066-2072.
16. Turski W.A., Schwarcz R. On the disposition of intrahippocampally injected kynurenic acid in the rat. Exp. Brain Res. 71:1988;563-567.
17. Varasi M., Della Torre A., Heidempergher F., Pevarello P., Speciale C., Guidetti P., Wells D.R., Schwarcz R. Derivatives of kynurenine as inhibitors of rat brain kynurenine aminotransferase. Eur. J. Med. Chem. 31:1996;11-21.
18. Wu H.-Q., Lee S.-C., Schwarcz R. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus. Eur. J. Pharmacol. 390:2000;267-274.
19. Wu H.-Q., Salituro F.G., Schwarcz R. Enzyme-catalyzed production of the neuro-protective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo. Eur. J. Pharmacol. 319:1997;13-20.
20. Wu H.-Q., Ungerstedt U., Schwarcz R. Regulation of kynurenic acid synthesis studied by microdialysis in the dorsal hippocampus of unanesthetized rats. Eur. J. Pharmacol. 213:1992;375-380.